Istanbul Bilim Universty Medical Fac.

Istanbul 34394

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, Relapsing Multiple Sclerosis

Studies at this site

• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
• A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study) — Stopped early